{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:43:17Z","timestamp":1759963397582,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["No. 5-8"],"award-info":[{"award-number":["No. 5-8"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chengdu high-level clinical key specialty construction project","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10072-021-05284-1","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:18:40Z","timestamp":1619482720000},"page":"5425-5431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cognitive dysfunction in a patient with migraine and APT1A2 mutation: a case report"],"prefix":"10.1007","volume":"42","author":[{"given":"Pian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-4382","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"5284_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10:457\u2013470. https:\/\/doi.org\/10.1016\/s1474-4422(11)70048-5","journal-title":"Lancet Neurol"},{"key":"5284_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1468-2982.2002.00371.x","volume":"22","author":"L Lykke Thomsen","year":"2002","unstructured":"Lykke Thomsen L, Kirchmann Eriksen M, Faerch Romer S et al (2002) An epidemiological survey of hemiplegic migraine. Cephalalgia 22:361\u2013375. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00371.x","journal-title":"Cephalalgia"},{"key":"5284_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jnnp-2020-322850","volume":"91","author":"V Di Stefano","year":"2020","unstructured":"Di Stefano V, Rispoli MG, Pellegrino N et al (2020) Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry 91:764\u2013771. https:\/\/doi.org\/10.1136\/jnnp-2020-322850","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5284_CR4","unstructured":"(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211"},{"key":"5284_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/head.13053","volume":"57","author":"HG Sutherland","year":"2017","unstructured":"Sutherland HG, Griffiths LR (2017) Genetics of migraine: insights into the molecular basis of migraine disorders. Headache 57:537\u2013569. https:\/\/doi.org\/10.1111\/head.13053","journal-title":"Headache"},{"key":"5284_CR6","doi-asserted-by":"publisher","first-page":"3464285","DOI":"10.1186\/1129-2377-15-s1-b12","volume":"2016","author":"E Martinez","year":"2016","unstructured":"Martinez E, Moreno R, Lopez-Mesonero L et al (2016) Familial hemiplegic migraine with severe attacks: a new report with ATP1A2 mutation. Case Rep Neurol Med 2016:3464285. https:\/\/doi.org\/10.1186\/1129-2377-15-s1-b12","journal-title":"Case Rep Neurol Med"},{"key":"5284_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10194-012-0462-5","volume":"13","author":"J Barros","year":"2012","unstructured":"Barros J, Mendes A, Matos I, Pereira-Monteiro J (2012) Psychotic aura symptoms in familial hemiplegic migraine type 2 (ATP1A2). J Headache Pain 13:581\u2013585. https:\/\/doi.org\/10.1007\/s10194-012-0462-5","journal-title":"J Headache Pain"},{"key":"5284_CR8","doi-asserted-by":"publisher","first-page":"e231129","DOI":"10.1136\/bcr-2019-231129","volume":"12","author":"MG Rispoli","year":"2019","unstructured":"Rispoli MG, Di Stefano V, Mantuano E, De Angelis MV (2019) Novel missense mutation in the ATP1A2 gene associated with atypical sporapedic hemiplegic migraine. BMJ Case Rep 12:e231129. https:\/\/doi.org\/10.1136\/bcr-2019-231129","journal-title":"BMJ Case Rep"},{"key":"5284_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0039-3400986","volume":"51","author":"Y Du","year":"2020","unstructured":"Du Y, Li C, Duan FJ, Zhao C, Zhang W (2020) Early treatment in acute severe encephalopathy caused by ATP1A2 mutation of familial hemiplegic migraine type 2: case report and literature review. Neuropediatrics 51:215\u2013220. https:\/\/doi.org\/10.1055\/s-0039-3400986","journal-title":"Neuropediatrics"},{"key":"5284_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1177\/0333102419847738","volume":"39","author":"W Tang","year":"2019","unstructured":"Tang W, Zhang M, Qiu E, Kong S, Li Y, Liu H, Dong Z, Yu S (2019) A Chinese family with familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2. Cephalalgia 39:1382\u20131395. https:\/\/doi.org\/10.1177\/0333102419847738","journal-title":"Cephalalgia"},{"key":"5284_CR11","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1097\/wnp.0000000000000387","volume":"35","author":"OC Murphy","year":"2018","unstructured":"Murphy OC, Merwick A, O'Mahony O, Ryan AM, McNamara B (2018) Familial hemiplegic migraine with asymmetric encephalopathy secondary to ATP1A2 mutation: a case series. J Clin Neurophysiol 35:e3\u2013e7. https:\/\/doi.org\/10.1097\/wnp.0000000000000387","journal-title":"J Clin Neurophysiol"},{"key":"5284_CR12","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/0333102418761041","volume":"38","author":"ME Hiekkala","year":"2018","unstructured":"Hiekkala ME, Vuola P, Artto V, H\u00e4pp\u00f6l\u00e4 P, H\u00e4pp\u00f6l\u00e4 E, Veps\u00e4l\u00e4inen S, Cuenca-Le\u00f3n E, Lal D, Gormley P, H\u00e4m\u00e4l\u00e4inen E, Ilmavirta M, Nissil\u00e4 M, S\u00e4k\u00f6 E, Sumelahti ML, Harno H, Havanka H, Keski-S\u00e4ntti P, F\u00e4rkkil\u00e4 M, Palotie A, Wessman M, Kaunisto MA, Kallela M (2018) The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: a clinical and genetic study in Finnish migraine families. Cephalalgia 38:1849\u20131863","journal-title":"Cephalalgia"},{"key":"5284_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0333102418761041","volume":"39","author":"G Schwarz","year":"2018","unstructured":"Schwarz G, Anzalone N, Baldoli C et al (2018) Pediatric sporadic hemiplegic migraine (ATP1A2 gene): a case report and brief literature review. Neurol Sci 39:69\u201371. https:\/\/doi.org\/10.1177\/0333102418761041","journal-title":"Neurol Sci"},{"key":"5284_CR14","doi-asserted-by":"publisher","first-page":"bcr2013009750","DOI":"10.1136\/bcr-2013-009750","volume":"2013","author":"A Merwick","year":"2013","unstructured":"Merwick A, Fernandez D, McNamara B, Harrington H (2013) Acute encephalopathy in familial hemiplegic migraine with ATP1A2 mutation. BMJ Case Rep 2013:bcr2013009750. https:\/\/doi.org\/10.1136\/bcr-2013-009750","journal-title":"BMJ Case Rep"},{"key":"5284_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1177\/0333102416651284","volume":"37","author":"N Pelzer","year":"2017","unstructured":"Pelzer N, Blom DE, Stam AH, Vijfhuizen LS, Hageman ATM, van Vliet J, Ferrari MD, van den Maagdenberg A, Haan J, Terwindt GM (2017) Recurrent coma and fever in familial hemiplegic migraine type 2. A prospective 15-year follow-up of a large family with a novel ATP1A2 mutation. Cephalalgia 37:737\u2013755. https:\/\/doi.org\/10.1177\/0333102416651284","journal-title":"Cephalalgia"},{"key":"5284_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/0333102413498941","volume":"34","author":"C Costa","year":"2014","unstructured":"Costa C, Prontera P, Sarchielli P, Tonelli A, Bassi MT, Cupini LM, Caproni S, Siliquini S, Donti E, Calabresi P (2014) A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. Cephalalgia 34:68\u201372. https:\/\/doi.org\/10.1177\/0333102413498941","journal-title":"Cephalalgia"},{"key":"5284_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mgg3.24","volume":"1","author":"O Carreno","year":"2013","unstructured":"Carreno O, Corominas R, Serra SA et al (2013) Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies. Mol Genet Genomic Med 1:206\u2013222. https:\/\/doi.org\/10.1002\/mgg3.24","journal-title":"Mol Genet Genomic Med"},{"key":"5284_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2020.07.009","volume":"112","author":"F Dannenberg","year":"2020","unstructured":"Dannenberg F, Prager C, Schmidt F, Tietze A, Bittigau P, Kaindl AM (2020) Intravenous nimodipine treatment for severe episode of ATP1A2 hemiplegic migraine. Pediatr Neurol 112:71\u201372. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2020.07.009","journal-title":"Pediatr Neurol"},{"key":"5284_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/dmcn.14261","volume":"62","author":"V Humbertclaude","year":"2020","unstructured":"Humbertclaude V, Riant F, Krams B, Zimmermann V, Nagot N, Annequin D, Echenne B, Tournier-Lasserve E, Roubertie A, Episodic Syndrome Consortium, Bonnemains C, Chabrier S, Cheuret E, Doummar D, Dubois F, Kossorotoff M, Leboucq N, Leydet J, Lion-Fran\u00e7ois L, Meyer P, Milh M, Napuri S, Nguyen MA, Nogue E, Panagiotakaki E, Pr\u00e9claire E, Rivier F, Saint Martin A, Sanchez S, Sarret C, Spitz MA, Tardieu M, Tourniaire B, Walther-Louvier U (2020) Cognitive impairment in children with CACNA 1A mutations. Dev Med Child Neurol 62:330\u2013337. https:\/\/doi.org\/10.1111\/dmcn.14261","journal-title":"Dev Med Child Neurol"},{"key":"5284_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12883-020-01704-5","volume":"20","author":"R Nardello","year":"2020","unstructured":"Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F, Raieli V, Fontana A (2020) Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol 20:155. https:\/\/doi.org\/10.1186\/s12883-020-01704-5","journal-title":"BMC Neurol"},{"key":"5284_CR21","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1038\/nature16029","volume":"527","author":"MJ Boivin","year":"2015","unstructured":"Boivin MJ, Kakooza AM, Warf BC, Davidson LL, Grigorenko EL (2015) Reducing neurodevelopmental disorders and disability through research and interventions. Nature 527:S155\u2013S160. https:\/\/doi.org\/10.1038\/nature16029","journal-title":"Nature"},{"key":"5284_CR22","doi-asserted-by":"publisher","first-page":"S390","DOI":"10.1542\/peds.2017-0852","volume":"141","author":"K Ueda","year":"2018","unstructured":"Ueda K, Serajee F, Huq AM (2018) Clinical benefit of NMDA receptor antagonists in a patient with ATP1A2 gene mutation. Pediatrics 141:S390\u2013S394. https:\/\/doi.org\/10.1542\/peds.2017-0852","journal-title":"Pediatrics"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05284-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:13:55Z","timestamp":1638566035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05284-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5284"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05284-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because the patient is under 18 years old, the patient\u2019s mother signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient\u2019s mother signed the informed consent form for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}